| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_30318ebd82c593a8296942f47eba97d4 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P21-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K1-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-00 |
| filingDate |
2001-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eaccc606c54fec7d3bb45406be9819e2 |
| publicationDate |
2002-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20020029859-A |
| titleOfInvention |
Direct separation and extraction of type i atelocollagen |
| abstract |
Telopeptide, located at the molecular end of collagen type 1, is the main cause of immune response. When used as a raw material for medicines or cosmetics, telopeptide is removed by treating soluble collagen with pepsin again. Collagen (atelocollagen) is used. However, this method requires a multi-step process, which is disadvantageous in that it takes time and cost. The present invention provides a simple and economical method for directly separating and extracting high purity atelo collagen by putting mammalian tissue in an acid solution and pulverizing the enzyme immediately. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011142543-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006096027-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101158338-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100465015-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100676285-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102933595-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011142543-A3 |
| priorityDate |
2000-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |